Global reach Spatz Medical markets Spatz3 in over 60 markets with a patient base exceeding 150,000, indicating a broad international footprint and potential for cross-border sales and partnerships, especially with distributors in high-need markets.

Adjustable advantage The only adjustable gastric balloon offering tailored volume to improve weight loss outcomes presents a differentiator for clinician adoption and upsell opportunities with obesity treatment programs and centers seeking flexible solutions.

Clinical credibility Clinical trial success and real-world effectiveness, including a strong weight loss track record and an 84% success rate cited in Lancet-backed data, provide compelling talking points for revenue growth and payer discussions.

Growth potential A low headcount with global reach and a revenue range of 1–10 million suggests partner-driven expansion via distributors, regional sales teams, and OEM collaborations to accelerate market penetration.

Digital & data Tech stack focused on marketing automation and analytics (HubSpot, Google Cloud, Hotjar, Demandbase) enables scalable lead generation, targeted campaigns, and performance measurement to optimize sales funnel conversion.